Written and maintained by CASRAI Editorial Board
Last updated
Short answer. An scFv (single-chain variable fragment, also written single-chain antibody) is an engineered antibody fragment in which the heavy-chain variable domain (VH) and light-chain variable domain (VL) are joined by a flexible peptide linker into one polypeptide of roughly 25-30 kDa. It keeps the antigen-binding site of an antibody but drops the constant regions, including the Fc.
This page is for researchers and lab staff who meet the term in papers, reagent catalogues or CAR-T and phage display protocols and need to know what the fragment is, how it differs from related formats, and what its structure means at the bench. It is general scientific information, not medical advice.
Definition and scope
The names scFv, scFv antibody, single-chain variable fragment, single-chain antibody and single-chain antibodies all describe the same format. In the source literature an scFv is “constituted by the VH and VL chains connected by a flexible polypeptide linker” (Muñoz-López et al., Cancers (Basel) 2022;14(17):4206, read 2026-11-08). A closely related phrase, Fv fragment, refers to the VH and VL pair without a linker; the scFv is the form in which that pair is held together as a single chain.
Because the constant domains are absent, an scFv has no Fc region. See the Fc domain of an antibody for what that region normally contributes. Full-length antibodies are compared in polyclonal vs monoclonal antibodies.
How an scFv is built and used
The linker and domain order
The linker is typically rich in glycine and serine; (Gly4Ser)3, often written (G4S)3, is the common example (Lou and Cao, Cancer Communications 2022;42(9):804-827, read 2026-11-08). Muñoz-López et al. report that scFvs with 15-20 amino acid linkers have shown the best binding properties, and that both orientations, VH-linker-VL and VL-linker-VH, have been used successfully.
Where scFvs are generated and used
- Phage display. Muñoz-López et al. note that phage display allows the generation of completely human antibody fragments. Library construction and selection are described in phage display: M13 libraries and biopanning.
- CAR-T cells. Chimeric antigen receptor T cells express an scFv on their surface, and Lou and Cao describe the antigen-binding domain (scFv or nanobody) as arguably the most critical component of a CAR.
- Bispecific T-cell engagers. Muñoz-López et al. describe BiTE molecules as two scFvs linked together.
Linker length and related fragment formats
Changing the linker changes the assembled format. The table is drawn only from the two reviews cited below.
| Format | What the source says | Source |
|---|---|---|
| scFv | VH and VL on one chain; about 25-30 kDa; 15-20 residue linkers gave the best binding | Muñoz-López et al. 2022 |
| Diabody | Forms with linkers shorter than 11 amino acids; bivalent, assembled from two chains | Lou and Cao 2022; Muñoz-López et al. 2022 |
| Triabody / tetrabody | Form with linkers shorter than 3 amino acids | Lou and Cao 2022 |
| Nanobody | 12-15 kDa single domain, about half the size of an scFv (25 kDa) | Lou and Cao 2022 |
Where it matters for labs
The two reviews support a short scFv versus full-length IgG comparison:
| Property | scFv | Full-size IgG |
|---|---|---|
| Fc region | Absent; avoids side effects conditioned by the Fc portion | Present |
| Tissue penetration | Reported as superior | Lower, by comparison |
| Half-life | Less than 1 day | About 3 weeks |
| Stability | Less stable; tends to form aggregates under thermal stress | Not described as an aggregation concern in these sources |
Source: Muñoz-López et al. 2022. The practical reading for planning experiments is editorial: any assay, purification or detection step that relies on the Fc region cannot be assumed to work with an scFv, so scFvs are usually handled through an added tag instead. For isotype-based detection see antibody isotyping.
Common misunderstandings
- An scFv is not a smaller copy of a whole antibody. It is a different molecule with no constant domains, a different half-life and its own aggregation behaviour.
- Linker length is not cosmetic. Shorter linkers drive diabody, triabody or tetrabody formation (Lou and Cao 2022).
- Domain order is not fixed. Both VH-linker-VL and VL-linker-VH are reported to work, so the order is a design choice to test.
- A nanobody is not an scFv. A nanobody is a single domain; an scFv needs both VH and VL.
FAQ
What is an scFv antibody?
An engineered fragment that joins an antibody’s VH and VL domains with a flexible linker into one chain of about 25-30 kDa, keeping the antigen-binding site but not the Fc.
Are scFv, single chain antibody and single-chain variable fragment the same thing?
Yes. They are alternative names for the same format. “Fv fragment” refers to the VH-VL pair itself.
Why do CAR-T cells use scFvs?
The CAR’s antigen-binding domain is an scFv or a nanobody, and the CAR-T cell displays it on its surface (Muñoz-López et al. 2022; Lou and Cao 2022).
How long does an scFv last compared with IgG?
The source reports a half-life under 1 day, against about 3 weeks for full-size IgG.
Sources
- Muñoz-López P, et al. Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy. Cancers (Basel) 2022;14(17):4206. pmc.ncbi.nlm.nih.gov/articles/PMC9455005 (read 2026-11-08).
- Lou H, Cao X. Antibody variable region engineering for improving cancer immunotherapy. Cancer Commun 2022;42(9):804-827. pmc.ncbi.nlm.nih.gov/articles/PMC9456695 (read 2026-11-08).
